期刊
FRONTIERS IN GENOME EDITING
卷 3, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fgeed.2021.618111
关键词
hemoglobin; sickle cell disease; thalassemia; epigenome editing; targeted DNA methylation; targeted histone modification; designer epigenome modifiers; CRISPR-dCas9
资金
- European Union [765269]
- Baden-Wuerttemberg Ministry of Science
- University of Freiburg
- Marie Curie Actions (MSCA) [765269] Funding Source: Marie Curie Actions (MSCA)
Tissue oxygenation depends on the activity of hemoglobin, mutations or dysregulation of which can lead to hemoglobinopathies. Advances in understanding the complex mechanisms controlling globin gene expression and protective genetic traits have led to the exploration of innovative therapeutic approaches for hemoglobinopathies.
Tissue oxygenation throughout life depends on the activity of hemoglobin (Hb) one of the hemeproteins that binds oxygen in the lungs and secures its delivery throughout the body. Hb is composed of four monomers encoded by eight different genes the expression of which is tightly regulated during development, resulting in the formation of distinct hemoglobin tetramers in each developmental stage. Mutations that alter hemoglobin structure or its regulated expression result in a large group of diseases typically referred to as hemoglobinopathies that are amongst the most common genetic defects worldwide. Unprecedented efforts in the last decades have partially unraveled the complex mechanisms that control globin gene expression throughout development. In addition, genome wide association studies have revealed protective genetic traits capable of ameliorating the clinical manifestations of severe hemoglobinopathies. This knowledge has fueled the exploration of innovative therapeutic approaches aimed at modifying the genome or the epigenome of the affected cells to either restore hemoglobin function or to mimic the effect of protective traits. Here we describe the key steps that control the switch in gene expression that concerns the different globin genes during development and highlight the latest efforts in altering globin regulation for therapeutic purposes.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据